Funding for this research was provided by:
Foundation for the National Institutes of Health (UL1TR002373)
University of Wisconsin Carbone Cancer Center (P30 CA014520)
Institute for Clinical and Translational Research, University of Wisconsin, Madison (Novel Methods in Translational Science)
U.S. Department of Veterans Affairs (Advanced Fellowship in Women's Health)
School of Medicine and Public Health, University of Wisconsin-Madison (T32 HL07899)
Received: 24 November 2021
Accepted: 25 March 2022
First Online: 25 April 2022
: Patients were consented under IRB-approved protocol (2014–1214) prior to any study procedures.
: Consent form available on request.
: David J. Beebe and Scott M. Berry hold equity in Salus Discovery LLC, which has licensed technology utilized in the manuscript. D. J. Beebe also holds equity in Tasso, Inc., Stacks for the Future, LLC, and Bellbrook Labs, LLC.